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Background: Most patients who sustain mild traumatic brain injury (mTBI) have persistent symptoms at 1 week
and 1 month after injury. This systematic review investigated the effectiveness of interventions initiated in acute
settings for patients who experience mTBI.
Methods: We performed a systematic review of all randomized clinical trials evaluating any intervention initiated in
an acute setting for patients experiencing acute mTBI. All possible outcomes were included. The primary sources of
identification were MEDLINE, Embase, PsycINFO, CINAHL, and the Cochrane Central register of Controlled Trials,
from 1980 to August 2012. Hand searching of proceedings from five meetings related to mTBI was also performed.
Study selection was conducted by two co-authors, and data abstraction was completed by a research assistant
specialized in conducting systematic reviews. Study quality was evaluated using Cochrane’s Risk of Bias assessment
tool.
Results: From a potential 15,156 studies, 1,268 abstracts were evaluated and 120 articles were read completely. Of
these, 15 studies fulfilled the inclusion/exclusion criteria. One study evaluated a pharmacological intervention, two
evaluated activity restriction, one evaluated head computed tomography scan versus admission, four evaluated
information interventions, and seven evaluated different follow-up interventions. Use of different outcome
measures limited the possibilities for analysis. However, a meta-analysis of three studies evaluating various follow-up
strategies versus routine follow-up or no follow-up failed to show any effect on three outcomes at 6 to 12 months
post-trauma. In addition, a meta-analysis of two studies found no effect of an information intervention on
headache at 3 months post-injury.
Conclusions: There is a paucity of well-designed clinical studies for patients who sustain mTBI. The large variability
in outcomes measured in studies limits comparison between them.
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Mild traumatic brain injury (mTBI) is defined as the
presence of head trauma, a Glasgow Coma Scale (GCS)
score of 13 to 15, and at least one of the following four
criteria: any period of loss of consciousness; any loss
of memory for events immediately before or after the
accident; any alteration in mental state at the time of the* Correspondence: graveljocelyn@hotmail.com
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reproduction in any medium, provided the oraccident (for example, feeling dazed); or focal neurological
deficit(s) that may or may not be transient [1,2].
The WHO estimates that the incidence of mTBI is of
600 cases per 100,000 adults in USA [3-5], with higher
incidence for young adults and athletes [3,6-11]. For
children, the WHO reports incidences varying from 50
to 100 cases per 100,000 children-years depending on
age [3,12-14]. Although most studies suggest that the
long-term evolution of mTBI is excellent, with complete
resolution of symptoms in 3 months [15-17], 55 to 90% of
patients who sustain mTBI experience post-concussion
symptoms during the week following the accident
[15,18,19]. The nature of these symptoms can be cognitiveLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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nausea), or psychological (depression, irritability).
Most patients requiring medical resources secondary to
mTBI are initially evaluated at the emergency department
(ED). Guidelines pertaining to the management of mTBI
generally recommend activity restriction and/or treatment
of symptoms [20-23]. Few studies have evaluated potential
interventions initiated in the ED for patients who sustain
mTBI. A systematic review by the WHO was conducted
to evaluate prevalence, outcome, and potential treatment
for mTBI [24,25]. Only 16 studies describing potential
treatments for mTBI were included. The main limitations
of that review were that it included articles published only
until the year 2000, and it did not evaluate the effects of
interventions on outcomes at 1 week and 1 month. The
objective of the current study was to identify all clinical
trials of interventions that could be initiated in an acute
setting for patients who sustain mTBI.
Methods
Design
This was a systematic review of the literature to identify
randomized clinical trials evaluating any intervention in the
acute phase of trauma versus any comparator or placebo
for patients with mTBI.
Data source and identification of studies
A database search strategy was formulated by one of
the authors (MW) who has experience in conducting
systematic reviews. A literature search was performed
to identify clinical trials and randomized clinical trials
including patients with mTBI (GCS score between 13
and 15) seeking acute treatment, and comparing any
intervention in the acute phase (first week) of trauma versus
any comparator or placebo. Main outcomes measured
were somatic post-concussion symptoms (headaches,
dizziness, vision, fatigue, irritability, or sleep problems).
Other symptoms also considered were cognitive symptoms
(memory, attention, concentration, cognition, and lan-
guage), psychological or emotional symptoms (anxiety,
depression, or irritability), autonomy, return to activity
(work, school or sport), physical disability, hospital or
emergency room readmission, and any side effects of the
intervention.
The literature search was conducted via OvidSP in the
following electronic databases: Embase, MEDLINE, EBM
Reviews, ACP Journal Club, Cochrane Central Register
of Controlled Trials, PsychINFO and CinHAL. A Boolean
search was constructed using the following MESH terms:
‘head, brain, cerebral, craniocerebral’ combined with any
of the following MESH terms: ‘trauma, injury, concussion
or post concussion’ and the following MESH term: ‘clinical
trial’. Appropriate MESH words were searched and adapted
to each database. The search was limited to human subjectsand articles published between 1980 and current (August
2012) with no language limitation.
An additional search was conducted in Google Scholar
and PubMed, in the references from relevant reviews and
clinical trials, and by using authors’ names and searching
in similar studies to identify potential additional clinical
trials. A hand search of conference proceedings of the
International Brain Injury Association, the International
Neuropsychological Society, the Society of the American
Association of Neurological Surgeon, the Society of Aca-
demic Emergency Medicine, and the Canadian Association
of Emergency Physicians was also conducted for the years
2010, 2011, and 2012.
Inclusion criteria were: trials including patients, without
age restriction, seeking acute treatment after a head trauma,
with a GCS score between 13 and 15, and one of the
following symptoms:
 Temporary loss of consciousness
(less than 30 minutes).
 Amnesia of less than 24 hours.
 Altered state of consciousness.
 Transient focal neurological deficit.
All interventions were eligible. These included, but were
not limited to, medications, psychological therapy, patient
education (including brochure, pamphlets or meeting with
a health professional), activity restriction, hospitalization,
or bed rest, and follow-up in a specialized clinic.
Exclusion criteria were: all trials concerning only moder-
ate to severe cases of TBI (GCS <13); clinical trials where
time between the trauma and the intervention was more
than 1 week; trials concerning only subgroups of patients
(for example, patients with insomnia); trials with diagnoses
or outcomes relevant only for moderate or severe TBI
(for example, death); trials where the extraction of data
regarding mTBI was not possible; and studies performed
on animals or cadavers.Study selection
Three authors (BC, AD, and JG) independently screened
in duplicate all titles and abstracts identified by the
search. The full manuscripts of all studies selected by at
least one reviewer were then evaluated independently
and discussed by two authors (BC and JG) to identify
the clinical trials to be included. Finally, the full manu-
scripts of the clinical trials were reviewed independently
in accordance with the inclusion and exclusion criteria,
and listed to select the final studies included in this
review. During these three steps, discrepancies were
discussed and resolved by consensus between the authors,
otherwise, a third author was consulted to reach an
agreement.
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Two authors (JG and MW) assessed the minimum inclu-
sion criteria for randomized clinical trials described in the
Cochrane Effective Practice and Organization of Care
(EPOC) review group [26]. To be included, a study had to
use a proper randomization tool to assign the patient
prospectively, have objective measurement of performance,
and have relevant and interpretable data presented or
obtained. Two authors (JG and MW) independently
assessed each study using the Risk of Bias tool for ran-
domized clinical trials described in the method guide for
comparative effectiveness [27]. The tool evaluated the
following risks of bias: selection (sequence allocation,
concealment, and confounding, analysis of patients in
the group to which they were randomized), performance
(concurrent intervention and fidelity to protocol), attrition,
detection (length of follow-up, blinding of assessor, and
validity of measurement of intervention, outcomes and
confounders), and reporting bias. Each item received a
rating of ‘no’ if judged to be at high risk of bias, a rating
of ‘yes’ if judged to have a low risk of bias, and ‘unclear’
when the evaluator could not conclude the risk of bias.
Any discordance between the authors was discussed and
resolved by consensus. Each study was rated as having a
low, unclear, or potential risk of bias.
Data extraction and management
Two authors (JG and MW) independently extracted data
from each study using a standardized data-extraction
checklist. The database included: demographic data of the
study; general information (author, year of publication,
year of enrollment in the study, country of the study,
setting, study design, randomization tool used, and duration
of the follow-up); patient information (number of patients,
age, number of patients who dropped out, inclusion and
exclusion criteria, and diagnosis of mTBI on admission);
GCS score; intervention and comparator description;
category and number of patients in each group and out-
come description; category and measurement tools; and
results of outcome of interest in detail including somatic,
cognitive, emotional and ‘return to activities’ data. In cases
of missing data or lack of transparency, authors were
contacted for clarification. In the absence of a response,
the data were considered unattainable. Discordances
between reviewers were resolved by consensus. Data
were then entered into the Cochrane Review Manager
software (RevMan5, 2008) and checked for accuracy.
Analysis
The large heterogeneity in interventions, outcomes mea-
sured, and timing of assessment reported in the studies that
met our inclusion criteria limited meta-analytic possibilities.
A priori, it was decided to conduct a meta-analysis if two
or more studies fulfilled the following three criteria: 1) theyevaluated a similar intervention; 2) they measured the same
outcome; 3) they measured the outcome during the same
time frame. Based on the characteristics of the studies
identified, two meta-analyses were performed to assess the
mid-term effects (1 to 3 months) of information given
during the visit to the ED versus routine care, and long-
term effects (6 to 12 months) of phone or clinical follow-up
versus routine care. Dichotomous data were meta-analyzed,
using odds ratios (OR) with 95% CI as measures of effect
size, or Peto OR if the number of events in a group was
equal to 0. Inter-study variation was incorporated with the
assumption of a random effects model for the treatment
effect using the DerSimonian and Laird method and the
inverse variance method for dichotomous data when
heterogeneity between trials was significant or was greater
than 50% [26]. In all randomized clinical trials, outcomes
were directly compared between the control and the inter-
vention group on an intention-to-treat basis (ITT). The Q
and I2 tests were used for addressing heterogeneity [26]. If
significant heterogeneity was detected, subgroup analyses
were carried out by type of study intervention.
Ethics approval
Because the study did not involve recruitment or assessment
of any patients, no research ethics board evaluation was
necessary.
Results
After removing duplicates, the literature search initially
identified 15,156 potential studies (see Figure 1). Most of
these were excluded based on their title because they
were not related to mTBI. A total of 1,268 abstracts
were evaluated, and 1,163 were excluded because they
did not meet our inclusion/exclusion criteria. The full
manuscripts of 105 articles were evaluated in addition
to 15 articles identified through the bibliographies. Of
these, 17 articles describing 15 distinct studies fulfilled
the inclusion/exclusion criteria. A hand search of the
five conference proceedings failed to identify any other
potentially pertinent study.
The characteristics of the included studies are described
in Table 1. Only one study evaluated a pharmacological
intervention [28]. Four studies evaluated standardized
information sessions provided in the acute setting with
or without an information booklet [29-32]. Seven studies
evaluated follow-up interventions compared with no
follow-up or routine follow-up [33-39]. Two studies
evaluated activity restriction (full bed rest for 6 days
[40] and hospital admission for 24 hours [19]). Finally, one
study evaluated the long-term outcome of performing a
computed tomography (CT) scan of the head versus
admission for patients with mTBI [41]. The size of the
studies ranged from 17 to 2,602 participants, with a median
of 262 participants. Patients of all ages were included.
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98 clinical trials 
15 clinical trials +2 follow-ups
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Total of 18470 titles identified 
by our search 
Figure 1 Flow chart of studies.
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children and adults, and eleven studies involved only
adults or patients older than 15 years. Multiple outcomes
were measured at intervals varying between 3 days and 10
years post-trauma.
Of the 15 studies, 5 presented a potential risk of bias.
The main reasons for potential biases were related to the
randomization sequence generation and the inadequate
concealment of allocation of participants (Figure 2). The
risk of bias was unclear for six studies. Most of these had
unclear information about multiple components of the
Risk of Bias tool. The most problematic components were
sequence allocation and concealment.
Interventions
The only pharmacological study reported that, compared
with placebo, nasal administration of 10 μg bid of 1-
desamino-8-d-arginine-vasopressin (DDAVP) for 5 days
was associated with better performance on two memory
tests on the third day of treatment for adults who sustained
mTBI [28]. The main limitations of the study related to thesmall sample size (n = 17), the small statistical effect, and
the fact that the intervention had no influence on four
other cognitive outcomes.
Four studies evaluated a standardized information inter-
vention provided in the ED. Three studies [29-31] reported
that the intervention was not more effective than usual
care in decreasing post-concussion symptoms, while
one study [32] reported that meeting with a specialized
therapist and the provision of a 10-page information
booklet decreased post-concussion symptoms among
adults admitted for mTBI. One study suggested that
standardized information and reassurance provided at
the ED was associated with faster return to work and
social activities [30]. The baseline characteristics of these
studies allowed us to conduct a meta-analysis using two
studies [29,30] that reported outcomes on individual
signs or symptoms secondary to mTBI at 1 to 3 months
following a standardized information intervention provided
in the acute setting. However, the pooled data failed to
show an association between the intervention and the
persistence of headache (relative risk (RR) = 0.88; 95%
Table 1 Characteristics of the studies
First author,
publication year
Inclusion criteria Number of
participants
Intervention Outcomes and results Risk of biasa (specific areas of risk of bias)
Studies including children only
Bell [34] Age <16 years old, mTBI of <48
hours’ duration, n = 366
366 Scheduled phone contact in the
first 3 months, standardized instruction
handout, and a toll-free phone number
CDC booklet (Facts about concussion
and brain injury and where to get help),
versus usual care
Fewer symptoms and less effect of
symptoms on functioning at 6 months
for the intervention group according
to the post-traumatic symptom
composite score (52.6 versus 46.0).
No difference in general health
composite score
Low
Casey [29] 6 months to 14 years old. minor
head trauma but exclusion of
patients who loss consciousness
340 Discharge interview during which the
nurse explained a take-home booklet
of symptoms and phone follow-up
carried out the day after discharge,
versus usual care
No influence on a list of post-concussion
symptoms 1 month after the accident
Potential (unclear for sequence allocation,
concealment and blinding. No reporting of
confounding and poor outcome measure)
Ponsford [37] 6 to 15 years old, mTBI, GCS 13
to 15
130 Contacted in 48 hours and received
neuropsychological assessment in 5
to 7 days plus information booklet,
versus no follow-up and no booklet
Less post-concussion symptoms in
the intervention group at 3 months
Potential (not randomized, no concealment
confounding)
Studies including adults and
children
Af Geijerstam [41] > 5 years old, mTBI within the
previous 24 hours, GCS of 15
2602 Immediate CT scan of the head
versus admission
No statistically significant difference,
Glasgow outcome scale not returned to
normal at 3 months (21.4% versus 24.2%)
Low
Studies including mainly adults Pharmaceutical intervention
Filipova [28] 18 to 60 years old mTBI 17 Nasal DDAVP (10 μg twice daily) for
5 days versus placebo
Intervention was associated with better
results on information-processing test
(PASAT) and verbal logical memory
after 3 days of treatment. However,
no effect seen on four other tests
Low
Information at discharge
Hinkle [30] mTBI or skull fracture, GCS 13 to 15 1092 Standardized information at discharge,
versus standardized information plus
reassurance plus phone follow-up,
versus routine care
Patient return to work and social
activities in the information and
information plus reassurance group
occurred at least 1 week sooner than
in the routine treatment group
Unclear (sequence allocation, concealment,
blinding and outcome measure)
Mittenberg [32] Patients admitted for mTBI
(adults), GCS 13 to 15
58 A 1 hour meeting with a therapist plus
a 10 page manual plus a 10 minute
questionnaire, versus routine care
Intervention associated with shorter
duration of symptoms (33 versus 51
days) and fewer symptoms at follow-up
at 6 months
Unclear (sequence allocation, concealment,
blinding and confounding)
Paniak [31] Adults, mTBI in the previous 3
weeks, exclusion of patients
known to have psychiatric
disorder
119 Three to four hours of
neuropsychological and personality
assessment and treatment as needed
plus single session with investigator
session and a brochure, versus a





















Table 1 Characteristics of the studies (Continued)
single session with investigator and
a brochure
Follow-up strategies
Andersson [33,42] 16 to 60 years old, mTBI 395 Telephone contact at 2 to 8 weeks,
follow-up in rehabilitation medicine,
and outpatient appointment weekly
as needed, versus usual care
No difference in post-concussion
symptoms at 1 year or 10 years
after mTBI
Unclear (concealment)
Ghaffar [35] 16 to 60 years old, mTBI presenting
to the emergency department
191 Follow-up in a multidisciplinary
clinic within 1 week and then as
needed, and treatment according
to specific complaints, versus no
follow-up
No effect on the RPCSQ Unclear (sequence allocation, concealment,
confounding, blinding, and fidelity to
protocol)
Heskestad [36] > 15 years old, minimal, mild and
moderate TBI
326 Follow-up in neurosurgery clinic
within 12 to 17 days after the
accident, versus no follow-up
No effect of intervention on post-
concussion symptoms
Potential (not randomized. no concealment.
15% completed the study)
Ponsford [39] > 15 years old, mTBI 262 Contacted in 48 hours and received
neuropsychological assessment in
5 to 7 days plus information booklet,
versus no follow-up and no booklet
Fewer post-concussion
symptoms related to anxiety
in the intervention group at
3 months
Potential (not randomized, no concealment
confounding)
Wade [38] 16 to 65 years old, head injury of
any severity
1156 Approached at 7 to 10 days after
injury and offered additional
information, advice, support, and
intervention as needed, versus no
follow-up




De Kruijk [40] > 15 years old, mTBI of 6 hours
or more
107 Full bed rest for 6 days followed
by gradual mobilization versus
gradual mobilization
No effect of bed rest on
symptoms secondary to
concussion at 2 weeks, 3
months, and 6 months
Unclear (concealment, and fidelity to
protocol)
Lowdon [19] 18 to 50 years old, minor head
injury with loss of consciousness
114 Admission overnight versus
discharge
Admission had no effect on
the incidence and had a
deleterious effect on the
duration of symptoms for
6 weeks
Unclear (sequence allocation, concealment,
and fidelity to protocol)
Abbreviations: CDC Centers for Disease Control, CT computed tomography, DDAVP 1-deamino-8-D-arginine vasopressin, GCS Glasgow Coma Scale, mTBI mild traumatic brain injury, PASAT Paced Auditory Serial Addition
Test, RPCSQ Rivermead Post-Concussion Symptoms Questionnaire, SF-36 Short Form 36.
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Yes (low risk of bias) No (high risk of bias) Unclear
Figure 2 Summary of the risk of bias for the 15 studies.
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CI 0.10 to 3.31). The major limitations of this analysis
related to the fact that the study population was different
for the two articles (adults versus children) and that one
of the studies had a potential risk of bias according to our
evaluation. A funnel plot is provided in the supplementary
material (Figure 3).
Seven studies evaluated the effect of a follow-up inter-
vention compared with routine or no follow-up [33-39,42].
The interventions were of various types. For example, in
one study, the intervention consisted of a phone follow-up,
a neuropsychological evaluation at 1 week, and an informa-
tion booklet [37], while in another study, the intervention
was limited to a phone follow-up 2 to 8 weeks after the
trauma [33]. Three studies showed a positive effect of the
intervention [34,37,39]. These interventions were 1) an
information booklet, phone follow-up in 48 hours, and
follow-up in a specialized clinic 5 to 7 days after the
trauma (evaluated in two studies); and 2) scheduled
phone contact in the 3 months after trauma, in additiona. Headache
b. Vision impairment
Figure 3 Association between standardized information interventions
concussion symptoms at 1 to 3 months.to an information handout and an information booklet.
Importantly, two of these studies were potentially biased
according to our evaluation. A meta-analysis was possible
using four studies (one with children and three with
adults) [33,34,36,38] that reported outcomes on individual
signs or symptoms secondary to mTBI at 6 to 12 months
after trauma. No association was seen between the inter-
vention and headache (RR 0.98; 95% CI 0.80 to 1.37), poor
concentration (1.13; 95% CI 0.78 to 1.64), memory prob-
lems (RR 1.17; 95% CI 0.74 to 1.86), dizziness (RR 0.58
95% CI 0.10 to 3.31), vision problems (RR 0.86; 95% CI
0.65 to 1.14), fatigue (1.09; 95% CI 0.69 to 1.48), irritability
(1.03; 95% CI 0.79 to 1.35), anxiety (1.19; 95% CI 0.88 to
1.59), depression (1.16; 95% CI 0.91 to 1.49) or sensitivity
to noise (1.17; 95% CI 0.74 to 1.86) (Figure 4a-j; see sup-
plementary material). Many of these analyses identified
important heterogeneity between studies with I2 values
greater than 50%. However, secondary analysis of the two
studies [33,38] comparing follow-up intervention with no
follow-up showed a positive effect for follow-up interventioncompared with routine or no information on multiple post-
Figure 4 Association between follow-up interventions compared with routine or no follow-up on multiple post-concussion symptoms
at 6–12 months. (a) Memory, (b) poor concentration, (c) headache, (d) dizziness, (e) vision impairment, (f) fatigue, (g) irritability, (h) anxiety,
(i) depression, and (j) sensitivity to noise.
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adults (Figure 4a,b). Importantly, this sub-analysis showed
no heterogeneity between studies.
One large study (n = 2523 participants) failed to
show any effect at 6 months for patients with mTBIwho had an immediate head CT scan compared with
admission [41]. Finally, two studies evaluating differ-
ent strategies to restrict activity (full bed rest [40] or
admission [19]) failed to show a clinical effect at 2
weeks to 6 months.
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The reported primary outcomes were mostly related to
post-concussion symptoms using various measurement
tools (for example, Rivermead Post-Concussion Symptoms
Questionnaire (RPCSQ) [43], visual analog scale (VAS),
head injury checklist). Some studies reported data for
individual symptoms. For example, presence of headache
was assessed and reported in nine studies, and memory
problems and dizziness were reported in seven studies.
Other studies reported only a summary score for symptoms
(for example, RPCSQ) or quality-of-life tools (for example,
Short-Form Health survey [44], Glasgow Outcome Scale
[45]). There was also important variability in the timeframe
for outcome measurement. Only four studies reported
outcomes measured in the first 2 months after mTBI, and
five studies reported only outcomes occurring 6 months
after intervention.
Discussion
This systematic review identified 15 randomized clinical
trials evaluating an intervention provided or initiated
in an acute setting for patients who sustained mTBI.
Our study highlights the paucity of research regarding
treatment for mTBI. Moreover, we found that a pharma-
cological intervention for patients who sustained mTBI
has been evaluated in only one randomized clinical trial.
This is particularly surprising considering that patients
with mTBI represent more than 90% of all TBIs [21]. Our
systematic review highlights the important heterogeneity
in outcomes measured for patients who sustain mTBI.
Although most studies reported many outcomes, no sin-
gle primary outcome was clearly reported in the majority
of studies.
Two systematic reviews of treatments for mTBI have
been published previously. The WHO identified sixteen
studies of interventions for patients who sustained mTBI
[25], of which nine were randomized clinical trials and
eight described an intervention that could be initiated at
the ED. Three of the identified publications did not
fulfill the inclusion criteria for our study: one trial was
conducted before 1980 [46], another included only patients
with persistent post-concussion symptoms at 3 months
[47], and the third included all levels of TBI, from which it
was impossible to isolate patients with mTBI [48]. The
second systematic review, by Comper et al., identified
twenty studies (including nine randomized clinical trials)
of interventions for mTBI published between 1980 and
2003 [49]. Three of the randomized clinical trials failed
our inclusion criteria because they included only patients
with post-traumatic stress disorder [50] or headache 1
year after TBI [51], or because it was impossible to isolate
only patients who had sustained a mTBI [48]. The conclu-
sion of both reviews was that there was no high-quality
intervention study pertaining to mTBI. In addition, theirresults suggested that a minimal educational strategy that
also promotes return to activity as soon as possible might
be effective. Our systematic review identified nine new
studies not identified by the WHO review and eight not
identified in the Compers et al. review. The main reason
for this is because most of these studies were published
after the completion of the previous reviews. Although
our systematic review doubles the number of included
studies, our conclusions are similar. In addition, it is inter-
esting to note that no new randomized clinical trial on
pharmacological treatment for mTBI has been reported
for more than 20 years.
More recently, two systematic reviews focused on
psychological treatments for mTBI [52,53]. The first
review identified eight studies published between 2004 and
2006, in addition to ten studies described in a previous
article [52]. Of these eighteen articles, twelve described a
randomized clinical trial of which seven described an
intervention provided in an acute setting for mTBI. These
articles were all identified in our systematic review. This
review concluded that there is little evidence to support
any active treatment for mTBI but ‘patient educational
approaches may be beneficial if they are initiated in the
early period following injury’ [52]. The second review eval-
uated all psychological interventions for post-concussion
symptoms published until November 2008. The authors
identified seventeen randomized clinical trials, of which
eight fulfilled our inclusion criteria and were included
in our study. The authors concluded that there is some
evidence of a positive effect of cognitive behavioral therapy
for adults who sustain mTBI, whereas ‘information,
education or reassurance may not be as beneficial as
previously thought’ [53]. These results contrast with
two systematic reviews providing evidence to support
cognitive rehabilitation of patients who sustain stroke or
TBI [54,55]. However, all patients included in the first
systematic review had neurological deficits secondary to
stroke or TBI [54], whereas the second study included
only patients with moderate to severe TBI or patients
with mTBI who consulted a rehabilitation clinic for
persistent symptoms [55]. These patients do not reflect
our study population, and this may explain the difference
noted for the effects of cognitive rehabilitation.
The very small number of randomized clinical trials
for patients who sustain mTBI is surprising, considering
that these patients represent approximately 90% of all
patients with TBI. This has an important influence on
the research agenda regarding management of patients
who sustain mTBI. Even though we identified only one
pharmacological study for this study population, emergency
physicians frequently prescribe medication for patients
who have sustained mTBI [56]. There should be a rigorous
evaluation of the mid-term and long-term effects of such
medications on decreasing acute symptoms of mTBI. The
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logical studies are numerous. Publication bias is not likely
to be a factor because no pertinent study was identified by
our group in the conference proceedings of five relevant
conferences. Rather, there is probably a lack of proof-
of-concept research on pharmacological intervention.
However, it will be difficult to have an animal model for
post-concussion syndrome. Accordingly, clinical researchers
should not wait for animal data before suggesting clinical
trials for humans who sustain mTBI. Initial studies
could evaluate the effects at 1 week of symptom-driven
treatment for mTBI. Most guidelines suggest activity
restriction after mTBI [57,58], but our systematic review
failed to find a positive effect for this type of intervention,
and further study is needed in this area.
Our study highlights the wide variety of clinical outcomes
reported in the included studies. Furthermore, studies used
different measurement tools for the same outcome. For
example, post-concussion symptoms were reported
individually (for example,: presence or absence of headache)
or using a composite score grouping many symptoms
(for example,: Rivermead Post-Concussion Symptoms
Questionnaire (RPCSQ, VAS for each symptom, head
injury questionnaire). Variability was also related to the
timing of measurement. While one study evaluated the
effect of the intervention at 3 days, others measured it
at 6 to 12 months. Variability in outcome may be related
to the presence of divergent definitions of persistent
post-concussion syndrome. For example, persistent post-
concussion syndrome occurs after 3 months according to
the DSM-IV-TR [59], but after only 1 month according to
the ICD-10 [60]. This variability has been evoked in the
past, and authors have suggested standardization [61-63].
Moreover, the NIH, through the National Institute of
Neurological Disorders and Stroke (NINDS), developed
the Common Data Element (CDE) project (http://www.
commondataelements.ninds.nih.gov/#page=Default). The
goal of this initiative was to develop data standards for
neurology clinical research. The initiative permitted
the creation of common definitions and datasets to con-
sistently capture and record outcomes across clinical stud-
ies in neurology. In our systematic review, the outcomes
most commonly reported were the presence or absence of
headache, dizziness, or memory problems.
Limitations
The most important limitation to our systematic review
is related to the large heterogeneity of interventions and
outcomes. This limited our ability to group studies together
based on intervention. In addition, the wide diversity in
outcome measures and timing of their measurement
limited our ability to conduct a meta-analysis including
most studies. However, this in turn is one of the main
findings of this study, further supporting the need tostandardize definitions and methods in order to advance
research in the field. A qualitative description of the
interventions and the studies will help readers come to
a better understanding of the subject. As with all sys-
tematic reviews, there is an inherent limitation related
to publication bias. The small number of studies and their
heterogeneity limited our ability to evaluate the extent of
publication bias.
Conclusion
Our systematic review demonstrates a paucity of clinical
trials for patients who sustain mTBI. According to the
published literature, no intervention initiated acutely has
been clearly associated with a positive outcome for patients
who sustain mTBI, and there is little evidence suggesting
that follow-up interventions may be associated with a
better outcome. Considering the high proportion of patients
with persistent symptoms after mTBI, it would seem
essential to evaluate potential treatments to decrease these
symptoms.
Finally, the large spectrum of outcomes evaluated for
patients who sustain mTBI limits the possibilities for
comparing treatments. Although a composite index score
(continuous data) comprising many symptoms secondary
to mTBI may be more useful for research purposes,
researchers should also collect data on individual symptoms
to permit comparison of studies. In addition, researchers
should measure outcomes at 1 week, 1 month and 3 months
after trauma. One potential research idea may be to ask
patients having sustained a mTBI what outcomes would
be meaningful for them.
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